SE0501903L - Borföreningar användbara vid BNCT - Google Patents

Borföreningar användbara vid BNCT

Info

Publication number
SE0501903L
SE0501903L SE0501903A SE0501903A SE0501903L SE 0501903 L SE0501903 L SE 0501903L SE 0501903 A SE0501903 A SE 0501903A SE 0501903 A SE0501903 A SE 0501903A SE 0501903 L SE0501903 L SE 0501903L
Authority
SE
Sweden
Prior art keywords
bnct
compounds
compounds useful
boron compounds
boron
Prior art date
Application number
SE0501903A
Other languages
English (en)
Other versions
SE528407C2 (sv
Inventor
Lars-Inge Olsson
Arne Eek
Erwan Arzel
Original Assignee
Hammercap Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hammercap Ab filed Critical Hammercap Ab
Priority to SE0501903A priority Critical patent/SE0501903L/sv
Priority to EP06769619.5A priority patent/EP1915381B1/en
Priority to PCT/SE2006/000952 priority patent/WO2007021234A1/en
Priority to US11/990,634 priority patent/US8183247B2/en
Priority to RU2008110472/04A priority patent/RU2423368C2/ru
Priority to CN2006800301784A priority patent/CN101268085B/zh
Priority to JP2008526905A priority patent/JP5053277B2/ja
Priority to TW095130337A priority patent/TWI376381B/zh
Publication of SE528407C2 publication Critical patent/SE528407C2/sv
Publication of SE0501903L publication Critical patent/SE0501903L/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/69—Boron compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C07F5/027—Organoboranes and organoborohydrides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • C07D475/02—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4
    • C07D475/04—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4 with a nitrogen atom directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Radiation-Therapy Devices (AREA)
SE0501903A 2005-08-19 2005-08-30 Borföreningar användbara vid BNCT SE0501903L (sv)

Priority Applications (8)

Application Number Priority Date Filing Date Title
SE0501903A SE0501903L (sv) 2005-08-19 2005-08-30 Borföreningar användbara vid BNCT
EP06769619.5A EP1915381B1 (en) 2005-08-19 2006-08-17 Boron compounds useful in bnct
PCT/SE2006/000952 WO2007021234A1 (en) 2005-08-19 2006-08-17 Boron compounds useful in bnct
US11/990,634 US8183247B2 (en) 2005-08-19 2006-08-17 Boron compounds useful in BNCT
RU2008110472/04A RU2423368C2 (ru) 2005-08-19 2006-08-17 Соединения бора, пригодные при борнейтронозахватной терапии
CN2006800301784A CN101268085B (zh) 2005-08-19 2006-08-17 用于硼中子俘获治疗的硼化合物
JP2008526905A JP5053277B2 (ja) 2005-08-19 2006-08-17 Ｂｎｃｔに有用なホウ素化合物
TW095130337A TWI376381B (en) 2005-08-19 2006-08-18 Boron compounds

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0501847 2005-08-19
SE0501903A SE0501903L (sv) 2005-08-19 2005-08-30 Borföreningar användbara vid BNCT

Publications (2)

Publication Number Publication Date
SE528407C2 SE528407C2 (sv) 2006-11-07
SE0501903L true SE0501903L (sv) 2006-11-07

Family

ID=37310298

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0501903A SE0501903L (sv) 2005-08-19 2005-08-30 Borföreningar användbara vid BNCT

Country Status (8)

Country Link
US (1) US8183247B2 (sv)
EP (1) EP1915381B1 (sv)
JP (1) JP5053277B2 (sv)
CN (1) CN101268085B (sv)
RU (1) RU2423368C2 (sv)
SE (1) SE0501903L (sv)
TW (1) TWI376381B (sv)
WO (1) WO2007021234A1 (sv)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007026701A1 (de) * 2007-06-01 2008-12-04 Universität Leipzig Neue chemische Verbindungen, deren Herstellung und deren Verwendung
CN101713740B (zh) * 2009-12-31 2012-05-02 中国原子能科学研究院 分光光度测量生物样品中bnct药物里硼含量的方法
CN104151339B (zh) * 2013-05-17 2017-05-03 中国科学院近代物理研究所 含硼吖啶衍生物、其制备方法和应用
JP6360113B2 (ja) * 2016-07-28 2018-07-18 ステラファーマ株式会社 ホウ素含有化合物
KR101903693B1 (ko) * 2016-11-28 2018-10-04 가천대학교 산학협력단 BSH 합성을 위한 티오피롤리딘을 이용한 Na2[B12H12] 반응
JP7154528B2 (ja) * 2017-08-25 2022-10-18 国立大学法人東京工業大学 ホウ素含有葉酸誘導体
KR20220003507A (ko) * 2019-03-04 2022-01-10 티에이이 라이프 사이언시스 붕소 중성자 포획 요법에서 사용하기 위한 보릴화된 아미노산 조성물 및 그의 방법
CN112358494B (zh) * 2020-04-09 2021-09-28 南京大学 一种基于吖啶的碳硼烷衍生物及其在生物显影中的应用
CN112442095B (zh) * 2020-12-01 2022-07-22 上海科黛生物科技有限公司 一种维生素b12的精制方法及所得产品的应用
CN112979686B (zh) * 2021-02-08 2022-04-08 北京大学 一种新型硼携带剂、制备方法及其药物制剂

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5272250A (en) 1992-07-10 1993-12-21 Spielvogel Bernard F Boronated phosphoramidate compounds
US6180766B1 (en) 1993-12-02 2001-01-30 Raymond F. Schinazi Nucleosides and oligonucleotides containing boron clusters
CN1124821A (zh) * 1994-02-14 1996-06-19 肖冠英 同步齿带半潜传动全贯流水电机组
US5630786A (en) * 1994-06-27 1997-05-20 Ionix Corporation Boron neutron capture enhancement of fast neutron therapy
JP2685128B2 (ja) * 1995-07-21 1997-12-03 東北大学長 カルボラン含有ガドリニウム−ｄｔｐａ錯体、その中間体、およびこれらの製造方法
US6093382A (en) * 1998-05-16 2000-07-25 Bracco Research Usa Inc. Metal complexes derivatized with folate for use in diagnostic and therapeutic applications
DE19905094C1 (de) 1999-02-01 2000-10-12 Schering Ag Gadolinium (III)-Komplexe sowie ihre Verwendung für Zweischritt Strahlentherapieformen und diese enthaltende pharmazeutische Mittel
JP2001233883A (ja) * 2000-02-22 2001-08-28 Okayama Pref Gov Shin Gijutsu Shinko Zaidan カゴ状ホウ素化合物担持ポルフィリン錯体
WO2002064601A1 (fr) 2001-02-09 2002-08-22 Hiroyuki Kagechika Dérivés de dicarba-$i(closo)-dodécarborane
EP2581382A2 (en) * 2004-02-13 2013-04-17 The University Of British Columbia Radiolabeled compounds and compositions, their precursors and methods for their production
JP2005343858A (ja) * 2004-06-07 2005-12-15 Mebiopharm Co Ltd ホウ素イオンクラスター脂質及びこれを用いたリポソーム
JP2006096870A (ja) * 2004-09-29 2006-04-13 Stella Chemifa Corp ホウ素含有化合物

Also Published As

Publication number Publication date
SE528407C2 (sv) 2006-11-07
TW200740833A (en) 2007-11-01
CN101268085B (zh) 2012-06-20
JP2009504732A (ja) 2009-02-05
TWI376381B (en) 2012-11-11
RU2008110472A (ru) 2009-09-27
JP5053277B2 (ja) 2012-10-17
EP1915381A1 (en) 2008-04-30
EP1915381B1 (en) 2013-04-10
US20090227539A1 (en) 2009-09-10
RU2423368C2 (ru) 2011-07-10
CN101268085A (zh) 2008-09-17
WO2007021234A1 (en) 2007-02-22
EP1915381A4 (en) 2011-02-09
US8183247B2 (en) 2012-05-22

Similar Documents

Publication Publication Date Title
SE0501903L (sv) Borföreningar användbara vid BNCT
NO2017019I2 (no) Enzalutamid eller et farmasøytisk akseptabelt salt derav
TW200740773A (en) Diaminopyrimidines as P2X3 and P2X2/3 modulators
MY147994A (en) Azabiphenylaminobenzoic acid derivatives as dhodh inhibitors
ATE466002T1 (de) Substituierte benzo (d) isoaxol-3-yl-amin- verbindungen als analgetika
HK1123733A1 (en) Viral hepatitis treatment
UA102858C2 (ru) Производные пиридино-пиридинонов, способ их получения и применения в терапии
TW200745122A (en) New compounds I
CY1116885T1 (el) Υποκατεστημενα παραγωγα κυκλοεξυλομεθυλιου
JO2682B1 (en) Derivatives of alkynil-8.1-naphthayridone, preparations thereof and therapeutic use thereof
TN2011000172A1 (en) Therapeutic antiviral peptides
MX2010009022A (es) Derivados 16 alfa, 17 alfa-acetal glucocorticoesteroideos y su uso.
MX2010002210A (es) Derivados de catecolamina y profarmacos de los mismos.
EA201170753A1 (ru) Налмефена гидрохлорид дигидрат
MY159208A (en) A novel formulation of indomethacin
SE0401762D0 (sv) Novel compounds
MX2009013501A (es) Compuestos piperidinicos y sus usos.
NO20084852L (no) MGLUR5 modulatorer V
DK2040703T3 (da) Derivater af 2-benzoylimidazopyridiner, fremstilling deraf og terapeutisk anvendelse deraf
GEP20115243B (en) Novel camptothecin analogues compounds, a method for the preparation thereof and pharmaceutical compositions containing said compounds
MX2009000281A (es) Derivados tetrahidroisoquinolina, metodos de preparacion y usos medicinales de los mismos.
ATE433450T1 (de) Substituierte 1,4,8-triazaspiro 4.5 decan-2-on- verbindungen
MX2012007896A (es) Derivados de piridino-piridinonas arilsulfonamidas, su preparacion y su uso en terapeutica.
DE602007012313D1 (de) Als a2b-adenosinrezeptorantagonisten geeignete 5-phenyl-6-pyridin-4-yl-1,3-dihydro-2h-imidazoä4,5-büpyridin-2-onderivate
TW200745133A (en) New compounds II